Search results
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
Investor's Business Daily· 6 days agoThe biotech company showed 68% earnings growth last quarter. Sales gains came in at 21%. Halozyme...
Weekly softball standings - May 16
The Bismarck Tribune· 7 days agoSOFTBALL
Play These New ETFs to Tap Lucrative Weight Loss Drug Market
Zacks· 22 hours agoGlobal obesity rates have nearly tripled since 1975, per WHO and Goldman Sachs. The growing usage of...
Droplet-based mechanical transducers modulated by the symmetry of wettability patterns - Nature...
Nature· 5 days agoVibrations are usually transformed into other forms of motions and energy for output through the use of mechanical transducers29,30. Here we place/adhere different materials on a horizontally-vibrating ...
Google's AI Gemini, formerly Bard: How the generative AI chatbot works, how to access and use it
Business Insider· 7 days agoGoogle's Gemini AI chatbot, formerly known as Bard, is the company's latest attempt to win the...
Is Bluebird Bio Stock a Buy?
Motley Fool via Yahoo Finance· 7 days agos financial situation could improve as Lyfgenia starts making an impact, there's another problem: It has a serious competitor. Casgevy, another...
Cellular Therapy for Diabetes: What Progress Has Been Made?
Medscape· 6 days agoPancreatic islet transplantation has been offered since 2020 in about 10 certified French centers,...
A Once-in-a-Generation Investment Opportunity: 1 Artificial Intelligence (AI) Growth Stock to Buy...
The Motley Fool· 4 days agoArtificial intelligence (AI) has created a lot of buzz since early last year. Generative AI has...
Forbion-backed biotech Progentos debuts with $65M for MS drug
BioPharma Dive via Yahoo Finance· 3 days agoProgentos says the money will go toward expanding its pipeline and pushing an experimental treatment...
Microsoft Azure AI gains new LLMs, governance features
InfoWorld· 2 days agoMicrosoft today at its annual Build conference introduced several updates to Azure AI, the company’s...
